Cardlytics Proceeds Revenue Tightening Surrounded By Failing Business Economics (NASDAQ: CDLX)

.Financial writer highly recommends selling Cardlytics, Inc. because of decreasing unit business economics, profits difficulties, and negative financial patterns. Click for this CDLX upgrade.